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The CXC chemokines, interleukin-8 and growth-re-
lated oncogenea, are known to play a prominent part
in wound healing as well as in£ammatory skin disor-
ders, including psoriasis. Both chemokines are potent
neutrophil activators and were discussed as potential
stimuli in keratinocyte growth.We examined the action
of growth-related oncogene a and interleukin-8 in or-
ganotypic raft culture, which resembles in vivo skin in
several respects. Addition of growth-related oncogene
a and interleukin-8 resulted in a time- and concentra-
tion-dependent epidermal hyperproliferation in orga-
notypic cultures. In cryostat sections an increased
number of epidermal layers as well as signi¢cantly ele-
vated number of Ki-67-stained keratinocytes indicate
marked hyperproliferation with no evidence for the re-
duction of apoptotic cells. Terminal di¡erentiation was
shown to proceed in a regular fashion with formation
of a corni¢ed layer and the expression of suprabasal ker-
atins in addition to the presence of di¡erentiation mar-
kers. Interleukin-8-mediated hyperproliferation was
inhibited by a blocking human monoclonal antibody.
To demonstrate a speci¢c receptor-mediated action of
growth-related oncogene and interleukin-8, we used a
CXC receptor 2 monoclonal antibody or a CXC recep-
tor 2 selective nonpeptide antagonist, both of which
lead to inhibition of interleukin-8-mediated hyperpro-
liferation. Interleukin-1a caused induction of interleu-
kin-8 and growth-related oncogene a mRNA as well
as marked epidermal hyperproliferation. The interleu-
kin-1a-mediated hyperproliferation was markedly re-
duced by both the interleukin-8-speci¢c antibody and
the CXC receptor 2 antagonist, indicating close correla-
tion between the interleukin-8/CXC receptor 2 pathway
and interleukin-1-induced keratinocyte growth stimu-
lation. Our data indicate that interleukin-1 induces
overexpression of interleukin-8 and growth-related on-
cogene a in human keratinocytes. These changes corre-
late with characteristic functional alterations of the
epidermis as observed in psoriasis and wound healing.
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nterleukin (IL)-8 is a member of the CXC chemokine sub-
family of chemotactic cytokines and plays a major part in
the recruitment and activation of neutrophils at sites of in-
£ammation (Schr˛der and Christophers, 1986). Members of
this subfamily, including IL-8 and growth-related onco-
gene (GRO)a, are basic heparin-binding proteins and share a cy-
steine-X-cysteine motif near the amino terminus (Baggiolini
et al, 1995).
In human skin, predominant cellular sources of IL-8 are
activated monocytes, endothelial cells, and epidermal keratino-
cytes (Schr˛der et al, 1987, 1990; Schr˛der and Christophers,
1989). Although these cells are known to be potent producers of
IL-8 in vitro following stimulation with primary cytokines, such
as IL-1 or tumor necrosis factora, little is known concerning the
induction of IL-8 and GROa in vivo. Increased release of biolo-
gically active IL-1 has been shown in psoriatic keratinocytes and
in chronic in£ammatory skin diseases (Sauder et al, 1984; Bonifati
et al, 1997). In keratinocytes, IL-1a is stored intracellularly and can
be quickly released in case of epidermal infection or injury. IL-1
can therefore be considered a possible inducer of IL-8 and GROa
in vivo (Sticherling et al, 1993).
In addition to its neutrophil chemotactic properties, IL-8 was
shown to activate nonhematopoietic cells, including keratinocytes
and endothelial cells. It was reported to stimulate angiogenesis
(Nickolo¡ et al, 1994) and keratinocyte migration (Gyulai et al,
1994) as well as growth in submerged cultured keratinocytes
(Tuschil et al, 1992).
Both CXC chemokines, IL-8 and GROa, were isolated in
large amounts from psoriatic scales (Schr˛der and Christophers,
1986) and could be shown to be both colocalized and overex-
pressed in psoriatic epidermis (Kulke et al, 1996). GROa and IL-
8-induced signaling is mediated by speci¢c receptors on the
surface of the target cells, which are designated as CXC receptors
(CXCR) 1 and 2 (Ahuja et al, 1992). CXCR1 binds only IL-8
with high a⁄nity (Ahuja and Murphy, 1996). CXCR2, which
recently was shown to be overexpressed in psoriatic keratino-
cytes (Kulke et al, 1998), binds IL-8 as well as GROa and other
members of the CXC chemokine subfamily with similar
a⁄nities.
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Because signi¢cant amounts of these chemokines could be re-
covered from psoriatic scales it appears likely that they play a part
in causing the characteristic changes observed in this disease.
These changes include epidermal hyperproliferation with in-
creased mitotic activity of basal and suprabasal keratinocytes as
well as altered keratinocyte di¡erentiation accompanied by an in-
£ammatory in¢ltrate in the epidermal and dermal compartments.
In fact, these epidermal changes can be caused by local overex-
pression of growth factors and cytokines, which stimulate epider-
mal proliferation.
In vitro studies on epidermal keratinocytes employ culture sys-
tems in which the cells are submerged and thus surrounded by an
arti¢cial environment. Therefore, examination of keratinocyte
proliferation in submerged cell culture appears of limited
relevance.
We established an organotypic raft culture system that allows
the study of epidermal growth regulation in close similarity to
in vivo conditions. Using this culture system the e¡ects of both
chemokines, IL-8 and GROa, in comparison with epi-
dermal growth factor (EGF) and IL-1 were studied in organo-
typic raft cultures with regard to keratinocyte proliferation and
di¡erentiation.
MATERIALS AND METHODS
Reverse transcription^polymerase chain reaction analysis (reverse
transcription^PCR) One microgram of the RNA prepared from
frozen raft cultures was reverse transcribed using the Superscript RT-Kit
(Gibco BRL, Eggenstein, Germany) according to standard protocols.
Semiquantitative multiplex PCR with primers speci¢c for the following
was performed:
Glyceraldehyde-3-phosphate dehydrogenase and Ki-67 (50 -primer: 50 -
ATTACAAGACTCGGTCCCTG; 30 -primer: 50 -ACTGTCCCTATGAC
TTCTGG)
CXCR2 (50 -primer: 50 -AGCTGCTCTTCTGGAGGTGT; 30 -primer:
50 -TTAGAGAGTAG-TGGAAGTGTGC)
GROa (50 -primer: 50 -TGAACTGCGCTGCCAGTGC; 30 -primer: 50 -
GGCATGTTGCGCTGCCAGTGC)
Keratin 1 (50 -primer: 50 -CTTGCAGCAGTCCATCAG; 30 -primer: 50 -
CAGAGGGCATCTCTTTATC)
Keratin 5 (50 -primer: 50 -GTCAACTGTGTCCTTCC-GGAG; 30 -
primer: 50 -CTGCGGTTGGCAATCTCCTCA)
Keratin 16 (50 -primer: 50 -CTTCAGCAGCAGCAGCAG; 30 -primer: 50 -
TCGTGGTTCTTCCTCAGG)
Laminin (50 -primer: 50 -CGGATCCTAGATGCAAAGAG; 30 -primer:
50 -ACAGAGTCCGTTGAAGGGTGG)
Small proline-rich protein 1 (50 -primer: 50 -GCATGAATTCTCAGCA
GC; 30 -primer: 50 -CTTCTGCTTGGTCTTC-TG).
These were performed with the following speci¢cations: denaturation at
941C for 1min, annealing at 601C for 1min, and extension at 721C for
2min for 30 cycles. PCR products were separated on 1% agarose gels
and stained with ethidium bromide. Quanti¢cation of the reverse
transcription^PCR result was performed densitometrically using the
BioDoc Analysis Software (Scanpack3, Biometra, Goettingen, Germany).
RNA isolation RNAwas prepared from snap frozen raft cultures using
1ml per culture Trizol (Gibco BRL) as described. The RNA yield was
determined photometrically. RNAwas stored at ^701C.
Immunohistochemistry Air-dried serial 5^8 mm cryostat sections were
¢xed in acetone for 10min, incubated with monoclonal mouse anti-Ki-67
antibody (Dianova, Hamburg, Germany) or with monoclonal mouse anti-
CXCR2 or anti-CXCR1 antibody (both kindly provided by Genentech,
San Francisco, CA) for 1h, followed by incubation with a secondary biotin
conjugated anti-mouse immunoglobulin antibody for 1h. Detection of
bound antibodies was performed with an avidin^biotin^peroxidase
complex (ABC, Vector Laboratories, Burlingame, CA) and diamino-
benzidine (Sigma, Deisenhofen, Germany) as chromogen. Sections were
counterstained with hematoxylin. In the negative controls, the primary
antibody was substituted by an isotype matched antibody with irrelevant
speci¢city.
Organotypic raft culture Primary dermal ¢broblasts and keratinocytes
were prepared from foreskin and grown as previously reported (Mielke
et al, 1990). Third passage ¢broblasts (5^7105) were resuspended in 3ml
ice-cold collagen solution containing 5.3mg collagen type I (solved in 0.02 M
CH3COOH; Becton Dickinson, Bedford, MA), 1Dulbecco minimal
Eagle’s medium (Gibco BRL), 2 mM L-glutamine (Gibco BRL), 0.5%
NaHCO3 (Merck, Darmstadt, Germany), 66.7 mM HEPES (Sigma), and
0.03 M NaOH (Merck), and submerged cultured in Dulbecco minimal
Eagle’s medium (Cell Concepts GmbH, Umkirch, Germany )þ 10% fetal
bovine serum (Kraeber GmbH & Co, Wedel, Germany) for 5 d. Third
passage keratinocytes (5105) were seeded on to these collagen lattices
and submerged cultured for 4 d in keratinocyte growth medium (KGM
Bullet Kit, BioWhittaker Europe, Verviers, Belgium)þ 5% fetal bovine
serum. Raft cultures were lifted to the air-medium-interphase and
incubated in keratinocyte growth medium without bovine pituitary
extract and EGF, but with additional 5% fetal bovine serum and 1.25 mM
CaCl2. Growth factors and antibodies were added into the medium. Before
contacting the cultures, the IL-8 speci¢c antibody was preincubated with
medium-diluted IL-8. The receptor-speci¢c antibodies and antagonists
were added to the culture medium a minimum of 2 h earlier than the
cytokines. The medium, including growth factors and antibodies, was
renewed every 2^3 d. Raft cultures were harvested and frozen at ^701C.
Serial cryostat sections (5^8 mm) from frozen raft cultures were performed
and stained with hematoxylin^eosin. Every raft series included three
independent cultures and was repeated at a minimum twice.
Growth factors and cytokines EGF, IL-1a, IL-8, and GROa (Cell
Concepts) were solved in water in a concentration of 100 mg per ml and
stored as aliquots at ^201C.
Antibodies EGF receptor and IL-8-speci¢c antibodies were kindly
provided by Abgenix Inc. (Fremont, CA). The CXCR2-speci¢c antibody
was provided by Genentech. In the negative controls, the antibody was
substituted by an isotype matched antibody in a similar concentration,
but with irrelevant speci¢city.
CXCR2 selective receptor antagonists The two antagonists (SB-
225002 and SB-236210, kindly provided by SmithKline Beecham
Pharmaceuticals, King of Prussia, PA) were dissolved in dimethyl
sulfoxide at a concentration of 10 mM and used at a ¢nal concentration of
300 nM^1 mM in culture medium. Equal amounts of dimethyl sulfoxide
were used as negative control.
Detection of apoptotic cells in raft epidermis Apoptotic cells in
serial cryostat sections were detected by TUNEL (terminal
deoxynucleotidyl transferase-mediated nick end labeling) using the
ApoAlertTM DNA fragmentation assay kit (Clontech, Palo Alto, CA) as
recommended by the manufacturer’s. 30 -OH DNA ends were labeled
with £uorescent deoxyuridine triphosphate. Nonapoptotic cells were
counterstained with propidium-iodide (Sigma).
Detection of proliferating cells in raft epidermis Raft cultures
were grown in normal medium or supplemented with 100 ng IL-8 per ml.
After 4d of culture, the medium was supplemented with 10 mM
bromodeoxyuridine (BrdU) for 24 h. The cultures were washed twice
with phosphate-bu¡ered saline, harvested, and ¢xed in 7.5%
formaldehyde. Serial cryostat sections (4 mm) were performed from
para⁄n-embedded raft cultures, dried at 371C, and incubated with a
BrdU-speci¢c antibody (Amersham Life Science, Braunschweig,
Germany). Detection of bound antibodies was performed using the
Universal DAKOs-APAAP Kit (DAKOs Diagnostika, Hamburg,
Germany). The sections were counterstained with hematoxylin.
RESULTS
Keratinocyte di¡erentiation and epidermal strati¢cation
Rafts cultured in basal medium (BM) supplemented with 100 ng
IL-8 per ml show regular epidermal di¡erentiation and
strati¢cation, including formation of a stratum basale, as well as
multilayered stratum spinosum.The granular zone consists of one
to three cell layers covered by an orthokeratotic packed stratum
corneum (Fig 1D). Di¡erentiation and strati¢cation was ob-
served over a period of 16 d. On day 4 the epidermis consists of
one basal cell layer, one to two suprabasal layers, and a thin stratum
corneum with one to two layers (Fig 1B). On day 8 there was an
increased epidermal thickness visible with two to three suprabasal
layers (Fig 1C), which increased to about ¢ve layers on day 12
(picture not shown). Mitotic ¢gures were occasionally seen
within the basal layer at all investigated time-points. The dermis
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equivalent can be described as loose collagenous formation
containing isolated ¢broblasts (Fig 1A^D).
In contrast to nonsupplemented cultures (Fig 1A), organotypic
raft cultures grown with 100 ng IL-8 per ml developed a
markedly thickened epidermis with an increased number of
suprabasal and corni¢ed layers. Epidermal thickness was
increased by a minimum of 50%. Above the stratum basale the
stratum spinosum is 10 layers thick, followed by two to three
granular layers and a loose multilayered stratum corneum.
Epidermal thickening is visible at all investigated time-points.
Regular keratinocyte di¡erentiation in arti¢cial epidermis can
be demonstrated by expression of di¡erentiation markers. As
shown in Fig 2, raft cultures were analyzed by semiquantitative
reverse transcription^PCR in order to investigate the expression
of typical keratinocyte di¡erentiation markers.
As a basal lamina marker, laminin mRNA is regularly
expressed at all time-points (4^16 d). A slight downregulation of
mRNA expression occurs after day 4 (Fig 2A).
Keratin 5, a marker for basal keratinocytes, is continuously
downregulated in raft cultures during growth from day 4 to day
16 (Fig 2C).
Expression of keratin 1, a suprabasal keratinocyte marker, is
upregulated dependent on the time of culture. As shown in
Fig 2(B), mRNA expression is strongly induced on the eighth
day of growth.
Small proline-rich protein-1, which is known to be a marker
for terminal di¡erentiation, is equally expressed over the entire
time period of epidermis development (Fig 2D).
As seen in Fig 2(E), keratin 16 shows a permanent expression
pattern at every stage of growth. Keratin 16 is described as a
protein only expressed in hyperproliferative epidermis.
Expression of Ki-67, a known nuclear antigen, is restricted to
proliferating cells, whereas in resting cells Ki-67 is not detectable.
Proliferation of keratinocytes in arti¢cial skin can be
demonstrated by mRNA expression of Ki-67 in every analyzed
raft culture (Fig 2F). Expression of Ki-67 mRNA in raft
epidermis shows a time-dependent downregulation from day 4
to day16.
In addition, the mRNA expression of CXCR2 (Fig 2G) and
IL-8 (Fig 2H) can be demonstrated in all analyzed cultures.
E¡ect of chemokines
E¡ect of IL-8 and GROa When the chemokines IL-8 or GROa
were added to the cultures this resulted in marked epidermal hy-
perproliferation as demonstrated by an increased number of su-
prabasal and corni¢ed layers and an elevated number of Ki-67
expressing keratinocytes. This hyperproliferative chemokine
e¡ect is concentration dependent ranging from 50 to 250 ng
per ml.
In comparison with rafts grown in BM without chemokine
supplementation, cultures displaced with 50 ng IL-8 per ml show
an increase of approximately three times in the number of epider-
mal layers. The stratum corneum contains a minimum of ¢ve
layers in contrast to two to three layers present in unsupplemen-
ted cultures. Addition of 250 ng IL-8 per ml leads to a ¢ve to
seven times increase in epidermal thickness with three times as
many corni¢ed layers (pictures not shown).The same results were
obtained, when GROa was used. Both IL-8 and GROa promote
epidermal cell proliferation to nearly the same extent.
Ki-67 protein expression is clearly upregulated under the in-
£uence of IL-8. In contrast to unsupplemented cultures, 100 ng
IL-8 per ml leads to a two times, and 250 ng IL-8 per ml to
a four times increase in the number of proliferating Ki-67
expressing keratinocytes in raft epidermis (Fig 3).
In addition to the increased cellularity and an upregulated Ki-
67 expression, hyperproliferation was also shown by elevated
BrdU incorporation in IL-8 supplemented raft cultures. After 4
d of culture, with 100 ng IL-8 per ml supplemented raft cultures
show six times more replicating keratinocytes than cultures
grown in BM without any growth-stimulating chemokines
(Fig 4).
When a human anti-IL-8 monoclonal antibody was added to
the raft cultures, the IL-8-associated keratinocyte hyperprolifera-
tion became inhibited, as demonstrated by a decreased number of
Figure1. Time-dependent epidermis strati¢cation in organotypic
raft culture. Raft cultures were grown over a period of 16 d in BM (A)
or in medium supplemented with 100 ng IL-8 per ml (B,C,D). Cultures
were harvested on day 4 (B), day 8 (C), and day 16 (A+D). Cryostat sections
from frozen raft cultures were performed and stained with hematoxylin^
eosin. Scale bar¼ 50 mm.
Figure 2. Expression of di¡erentiation markers in arti¢cial epider-
mis. Total RNA of frozen raft cultures grown for 4^16 d in unsupplemen-
ted raft medium was prepared and reverse transcribed. Semiquantitative
multiplex reverse transcription^PCRwas performed with speci¢c primers
for glyceraldehyde-3-phosphate dehydrogenase (A^H) and speci¢c primers
for laminin (A), keratin 1 (B), keratin 5 (C), small proline-rich protein 1
(D), keratin 16 (E), Ki-67 (F), CXCR2 (G), or IL-8 (H). PCR fragments
were separated on 1% agarose gels and stained with ethidium bromide.
c¼ control reaction, bp¼100 base pair ladder .
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epidermal cell layers (Fig 5B) and a reduced number of prolifer-
ating Ki-67 expressing cells (Table I). Epidermal thickness and
number of proliferating cells were reduced to the same level ob-
served in cultures grown in normal, unsupplemented medium.
Inhibition of IL-8 could not be detected with a control antibody
of irrelevant speci¢city added to the IL-8 containing culture
medium.
E¡ect of EGF Addition of 10 ng EGF per ml resulted in a mark-
edly increased keratinocyte growth similar to the e¡ects of 100 ng
IL-8 per ml on epidermal growth. The number of suprabasal cell
layers increased 5-fold when 10 ng EGF per ml was added. Inter-
estingly, there was no increase of Ki-67 mRNA expression in
EGF-stimulated keratinocytes detectable.
In the presence of an EGF receptor speci¢c monoclonal anti-
body, complete inhibition of keratinocyte growth was noted
and the epidermal thickness was reduced to a minimum in cul-
tures with blocked EGF receptor. This strong inhibitory e¡ect of
the EGF antibody on keratinocyte growth could not be detected,
when a control antibody was added to the EGF containing cul-
ture medium (data not shown).
E¡ect of IL-1a IL-1a at a concentration of 100 ng per ml strongly
promoted keratinocyte growth resulting in an increase of cell
proliferation and epidermal thickening. Additionally, an approxi-
mately ¢ve times raise of Ki-67 expressing cells was detected.
(Table I).
Additionally, reverse transcription^PCR analysis of IL-1a-sti-
mulated raft cultures revealed an induction of IL-8 and GROa
mRNA. As shown in Fig 6, expression of GROa mRNA is
twice, whereas expression of IL-8 mRNA ¢ve times higher than
in unstimulated raft cultures.
In order to investigate further the mechanism by which IL-1a
acts on keratinocytes, a human IL-8-speci¢c monoclonal anti-
body was added to hyperproliferating IL-1a-stimulated cultures.
This resulted in a reduction of the number of epidermal layers by
approximately 50%. The morphologic changes of epidermal
thickness were ascertained by measuring the rates of proliferating
Ki-67-positive keratinocytes. As can be seen inTable I, addition
of the anti-IL-8 antibody resulted in a decrease of approximately
50% of the number of proliferating keratinocytes in IL-1a-sti-
mulated raft cultures.
Receptor-mediated e¡ects of IL-8 on keratinocytes The IL-
8-mediated keratinocyte hyperproliferation in raft epidermis was
inhibited by blocking the receptor protein CXCR2. Whereas
both receptors, CXCR1 and CXCR2, were expressed at the
mRNA level only CXCR2 could be detected at the protein
level by immunohistochemistry (data not shown). Receptor
blocking was performed by using either a CXCR2 speci¢c
monoclonal antibody, or the nonproteinous CXCR2 selective
receptor antagonist SB-225002. Both additives led to similar
results: inhibition of IL-8-mediated growth promotion of
keratinocytes in organotypic culture. This inhibition can be
demonstrated by reduction of IL-8-induced epidermal thickness
(Fig 5CþD) and additionally by a decreased amount of
Figure 3. Increased number of Ki-67-positive stained keratinocytes
in raft epidermis under the in£uence of IL-8. Raft cultures were
grown for 14 d in BM or with di¡erent concentrations of IL-8 (100 or
250 ng per ml). Serial cryostat sections were stained immunohistochemi-
cally with a Ki-67-speci¢c antibody. Bars show number of stained kerati-
nocytes (mean7SD) counted in a de¢ned epidermal area.
Figure 4. Increased number of BrdU incorporating keratinocytes in
raft epidermis under the in£uence of IL-8. After for 4 d of culture in
BM or in medium containing 100 ng IL-8 per ml, raft cultures were sup-
plemented with 10 mM BrdU for 24 h. Incorporated BrdU was detected im-
munohistochemically with a BrdU-speci¢c antibody. Bars show number
of stained keratinocytes (mean7SD) counted in a de¢ned epidermal area.
Figure 5. IL-8 induced hyperproliferation can be inhibited by
blocking of CXCR2. Raft cultures were grown over a period of 15 d in
medium supplemented with 100 ng IL-8 per ml (A), 100 ng per ml IL-
8+82.5 mg per ml anti-IL-8 antibody (B), 100 ng per ml IL-8+250 mg per
ml anti-CXCR2 antibody (C), or 100 ng per ml IL-8+1 mm SB22 (D).
Cryostat sections from frozen raft cultures were performed and stained
with hematoxylin^eosin. Scale bar¼ 50 mm.
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proliferating Ki-67-positive keratinocytes in raft epidermis
(Table I).
The number of epidermal layers as well as the quantity of
proliferating cells in CXCR2-blocked raft cultures was reduced
to the same level observed in organotypic cultures grown in
basal unsupplemented medium. This e¡ect was not seen with an
appropriate concentration of isotype matched control antibody
with irrelevant speci¢city or with dimethyl sulfoxide. Control
cultures developed a similarly thickened epidermis seen in IL-8-
stimulated raft cultures. The SB-225002 related substance SB-
236210 did not show any visible e¡ects on keratinocyte growth
in raft cultured epidermis (data not shown).
Addition of the CXCR2 selective receptor antagonist SB-
225002 to IL-1a-stimulated organotypic raft cultures resulted in
a similar keratinocyte growth inhibition to cultures grown in IL-
8 containing medium. Cell proliferation (Table I) as well as
epidermal thickening returned to the basal level of unstimulated
cultures. [Ongoing studies using the inhibitor of CXCR2 SB-
225002 and also anti-EGF receptor antibodies showed that these
were able to block epidermal thickening stimulated with IL-8 as
well as with GROa (unpublished).]
DISCUSSION
In this study we demonstrate that IL-8 and GROa both mark-
edly stimulate keratinocyte growth in organotypic cultures of
human skin. Also it is shown that IL-1 acts as a powerful growth
promoter by stimulating the secretion of IL-8 and GROa.
Raft cultures of human skin have provided a useful tool for the
study of human skin in vitro (Parenteau et al, 1992). They consist of
a dermal equivalent of collagen-embedded ¢broblasts covered by
keratinocytes. Being located exactly at the air^liquid interphase,
keratinocytes are able to form a multilayered epithelium within
days after seeding (Bell et al, 1991). In addition, strati¢cation and
the formation of keratinized cell layers ensues and, as revealed by
morphology, horny cell layers result from further di¡erentiation
of granular cells in the stratum granulosum (Fig 1).
Evidence for an in vivo-like terminal di¡erentiation of these
keratinocytes is provided by expression of distinct markers of ker-
atinocyte maturation.Within 4 d after seeding the so-called small
proline-rich protein 1 as a marker for cellular envelope formation
was noted in addition to mRNA for keratin 10, involucrin
(Fig 2), small proline-rich protein 2, transglutaminase, and pro-
tein kinase C (data not shown). The synthesis of these markers is
indicative for cell-speci¢c terminal di¡erentiation of the human
keratinocyte system (Watt, 1983; Bayerl et al, 1995; Fischer et al,
1998).
A concentration-dependent increase in keratinocyte numbers
and epidermal thickness is seen following the addition of
ELR(þ ) (glutamic acid-leucine-arginine motif positive) CXC
chemokines IL-8 and GROa. Augmented cell members include
suprabasal cells as well as corni¢ed cells and are likely to be the
result of increased proliferative activity of the basal layer shown
by the raised number of Ki-67-stained cells and Ki-67 mRNA.
This is further ascertained by BrdU staining demonstrating that
keratinocyte new cell production was raised two to four times
above controls (Fig 4). Therefore the increased epidermal thick-
ness seen in these raft cultures appears to result from IL-8 (or
GROa) induced stimulation of cell division in the basal cell layer.
Speci¢city of this process was supported by blocking experi-
ments using an anti-IL-8 antibody that completely abrogated an
IL-8-induced increase in epidermal cellularity (Fig 5). Also, the
expression of Ki-67 mRNA remained within the control range
indicating that the human antibody shows marked inhibitory
e¡ects in CXCR2-mediated hyperproliferation (Table I).
Interestingly, induction of epidermal growth was nearly iden-
tical with addition of either IL-8 or GROa at the same concen-
trations. Both chemokines act as ligands for CXCR2, in contrast
to CXCR1, which shows high a⁄nity for IL-8 only (Murphy,
1997). CXCR1 and CXCR2 appear to be di¡erentially expressed
Table I. Up/downregulation of Ki-67 mRNA and protein in organotypic culture. Raft cultures were grown in BM or supplemented with
growth factors and inhibitors as indicated. Induction of Ki-67 mRNA is demonstrated by semiquantitative multiplex reverse transcription^
PCRwith speci¢c primers for glyceraldehyde-3-phosphate dehydrogenase and Ki-67. PCR products were separated on an 1% agarose gel,
stained with ethidium bromide and analyzed densitometrically. Proliferating keratinocytes in arti¢cial epidermis were detected by immuno-
histochemistry with a Ki-67 speci¢c antibody and counted in a de¢ned epidermal area
Ki-67 mRNA expression Ki-67 mRNA expression Total no. of Ki-67 positive No. of Ki-67positive cells
Raft culture (PCR-data) (relative to BM) cells per area (relative to BM)
BM 0.08 1.00 4.40 1.00
IL-8 0.94 11.40 26.00 5.90
IL-8þaIL-8 0.07 0.88 7.33 1.67
antibody
IL-8þ SB22 0.23 2.80 0.90 0.20
IL-8þDMSO 0.50 6.00 26.00 5.90
IL-8þaCXCR2 0.21 2.48 T T
antibody
IL-8þ control 0.86 10.31 22.67 5.15
antibody
BM 0.08 1.00 8.60 1.00
IL-1a 1.76 22.00 39.80 4.63
IL-1aþSB22 0.04 0.48 T T
IL-1aþ aIL-8 1.03 12.88 T T
antibody
Figure 6. IL-1a induces upregulation of IL-8 and GROamRNA in
organotypic culture. Raft cultures were grown in BM or supplemented
with 100 ng IL-1a per ml. Induction of chemokines is demonstrated by
semiquantitative multiplex reverse transcription^PCR with speci¢c pri-
mers for glyceraldehyde-3-phosphate dehydrogenase and GROa (A) or
IL-8 (B). PCR products were separated on 1% agarose gels, stained with
ethidium bromide and analyzed densitometrically.
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in raft cultures, as CXCR1mRNA is detected, no CXCR1 pro-
tein is expressed (Michel et al, 1992; Mueller et al, 1994). Also, in a
previous study Kulke et al (1998) were unable to detect CXCR1 in
normal human or in psoriasis epidermis.Thus, in vivo as well as in
organotypic cultures the receptor for IL-8 and GROa appears to
be CXCR2. This observation was further supported by use of
CXCR2-speci¢c antibody (Fig 5), which completely blocked
chemokine (IL-8, GROa) induced keratinocyte growth.
Among the various chemokines/cytokines produced by human
keratinocytes IL-8 plays a major part.Whereas IL-8 initially was
detected as a powerful chemoattractant for neutrophils (Schr˛der
and Christophers, 1986) subsequent work by various groups has
revealed a comparatively broad spectrum of biologic activities
(for review see Schr˛der, 1995). These include proin£ammatory
e¡ects by activating in£ammatory cells (Barker et al, 1991), growth
promoting activities in tumor cell lines (Schadendorf et al, 1993)
and keratinocytes, and angiogenesis (Koch et al, 1992).
Previous studies (Sticherling et al, 1991) have demonstrated that
in human keratinocytes preformed IL-8 is present and is secreted
following stimulation. Normal keratinocytes were shown to con-
tain signi¢cant amounts of IL-8 protein as revealed by immune
histology (Sticherling et al, 1991) and this immunoreactivity was
readily lost following wounding or in£ammation (Sticherling et
al, 1992). Production of IL-8 by epithelial cells can be upregulated
by the addition of various cytokines (e.g., IL-1a, IL-1b, tumor
necrosis factor a; Larsen et al, 1989) or irritants (e.g., phorbol ester;
Schenk et al, 1996). In human keratinocytes cultured in vitro we
could show that IL-8 production was greatly augmented by the
addition of IL-1 and tumor necrosis factor a to the culture med-
ium (Schr˛der et al, 1990).
Furthermore, early and signi¢cant secretion of IL-8 was ob-
served when human keratinocytes were confronted with inacti-
vated bacterial membranes in vitro. Next to the generation of
anti-microbial defense peptides (e.g., hBD-2; Harder et al, 1997),
IL-8 production could be stimulated when living bacteria (Sta-
phylococcus aureus, Pseudomonas aeruginosa; Xue et al, 2000) were in
close physical contact with keratinocytes.
More recently, exposure of epithelial cells with P. aeruginosa re-
sulted in early expression of IL-8 (and IL-6) and was followed by
IL-1b and tumor necrosis factor a (Xue et al, 2000). Also, in vivo
exposure of epithelium to P. aeruginosa caused marked production
of CXCR chemokines (Tsai et al, 2000).When in these mice the
CXCR 2 was neutralized a marked increase in mortality ensued.
In this study it has been shown that with 100 ng IL-1 per ml an
increase in epidermal thickness can be obtained, which compares
with the e¡ects of high concentrations of IL-8 and GROa. This
e¡ect again was caused by stimulated cellular growth of basal
cells shown by greatly elevated levels of Ki-67 mRNA and pro-
tein (Table I). In order to analyze more closely this IL-1 e¡ect in
keratinocytes mRNA levels for IL-8 and GROa were deter-
mined and were found to be elevated, whereas IL-6 mRNAwas
not a¡ected by exposure of the cells to IL-1 (data not shown).
Furthermore, when organotypic raft cultures were stimulated
in the presence of the CXCR2 receptor antagonist, both prolif-
erative activity as well as epidermal thickness remained at control
levels (Fig 5). These data indicate that IL-1 indirectly stimulates
keratinocyte growth via the production of both IL-8 and GROa
and that these e¡ects are mediated by CXCR2. Indeed, the addi-
tion of an IL-8-speci¢c antibody to the IL-1-stimulated culture
system caused a near 50% reduction of growth (Table I). The
remaining growth potential is likely to be due to GROa,
which after being induced by IL-1 may still cause signaling by
binding to CXCR2.
Taken together our data provide strong evidence for potent
growth promoting e¡ects of both chemokines, IL-8 and GROa,
on human keratinocytes. This observation is of help in further
understanding the pleiotropic activities of IL-8.
In skin, the chemotactic and growth promoting e¡ects of IL-8
appear to play a major part especially in wound healing. Previous
work has shown that in skin wounding the concentrations of IL-
1 as well as IL-8 and GROa are markedly increased (Sauder et al,
1990; Nanney et al, 1995). Similarly elevated amounts of these cy-
tokines are seen in psoriatic epidermis and in£ammatory condi-
tions (e.g., contact dermatitis; Corsini and Galli, 1998). In psoriasis
the amounts of IL-8 recovered from scale material were higher
than any other cytokine studied (Schr˛der et al, 1992) suggesting
that this chemokine is of primary importance in epithelial
growth and defense. As shown (Schr˛der and Christophers,
1989), potent stimuli for IL-8 are provided by microbial agents
in contact with keratinocytes as well as the dominating proin-
£ammatory cytokine IL-1. Thus, under wound healing condi-
tions at least two stimuli for the secretion of IL-8 are operative.
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